Comprehensive Allelotype and Genetic Analysis of 466 Human Nervous System Tumors
暂无分享,去创建一个
A. Poustka | R. Fimmers | D. Louis | R. Wellenreuther | D. Maintz | J. Schramm | A. von Deimling | W. Wick | J. Henson | O. Wiestler | M. Platten | J. Koopmann | J. Mollenhauer | A. Waha | K. von Ammon | B. Meyer‐Puttlitz | R. Przkora | E. Duerr | P. Kaskel | Matthias C. Schmidt | B. Bender | B. Blümcke | A. Stangl | D. J. Müller | R. Jahnke | F. Fassbender | Stephanie Steinbeck | O. Schmidt | Daniel J. Müller | Ortrud Schmidt | Frank Fassbender
[1] D. Louis,et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. , 1998, Journal of the National Cancer Institute.
[2] D. Louis,et al. PTEN mutations in gliomas and glioneuronal tumors , 1998, Oncogene.
[3] K. Sasaki,et al. Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization , 1998, Genes, chromosomes & cancer.
[4] M. Prados,et al. Genetic analysis of glioblastoma multiforme provides evidence for subgroups within the grade , 1998, Genes, chromosomes & cancer.
[5] R. Wellenreuther,et al. Analysis of the PTEN gene in human meningiomas , 1998, Neuropathology and applied neurobiology.
[6] K. Plate,et al. p53 Mutations versus EGF Receptor Expression in Giant Cell Glioblastomas , 1997, Journal of neuropathology and experimental neurology.
[7] D. Louis,et al. Molecular Genetic Evidence for Subtypes of Oligoastrocytomas , 1997, Journal of neuropathology and experimental neurology.
[8] G. Reifenberger,et al. Molecular genetic analysis of giant cell glioblastomas. , 1997, The American journal of pathology.
[9] Jan Mollenhauer,et al. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3–26.1 is deleted in malignant brain tumours , 1997, Nature Genetics.
[10] D. Louis,et al. Association of EGFR Gene Amplification and CDKN2 (p16/MTS1) Gene Deletion in Glioblastoma Multiforme , 1997, Brain pathology.
[11] W. K. Alfred Yung,et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.
[12] M. Wigler,et al. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.
[13] W. B. Smith,et al. A Role for Endothelial NO Synthase in LTP Revealed by Adenovirus-Mediated Inhibition and Rescue , 1996, Science.
[14] C. Sommer,et al. Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. , 1996, Oncogene.
[15] B. Scheithauer,et al. The Glial and Mesenchymal Elements of Gliosarcomas Share Similar Genetic Alterations , 1996, Journal of neuropathology and experimental neurology.
[16] D. Louis,et al. Amplification of the cyclin-dependent kinase 4 (CDK4) gene is associated with high cdk4 protein levels in glioblastoma multiforme , 1996, Acta Neuropathologica.
[17] A. von Deimling,et al. A Polymerase Chain Reaction‐based Assay for the Rapid Detection of Gene Amplification in Human Tumors , 1996, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[18] G. Woude,et al. Abnormal Centrosome Amplification in the Absence of p53 , 1996, Science.
[19] I. Petersen,et al. Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer. , 1996, Oncogene.
[20] F. Waldman,et al. Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridization , 1995, International journal of cancer.
[21] D. Louis,et al. Shared Allelic Losses on Chromosomes 1p and 19q Suggest a Common Origin of Oligodendroglioma and Oligoastrocytoma , 1995, Journal of neuropathology and experimental neurology.
[22] C. James,et al. CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. , 1994, Cancer research.
[23] D. Louis,et al. MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p. , 1994, Human molecular genetics.
[24] P. Meltzer,et al. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. , 1994, Cancer research.
[25] R. Wellenreuther,et al. Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q. , 1994, Cancer research.
[26] A. von Deimling,et al. A device for processing large acrylamide gels. , 1994, BioTechniques.
[27] Olivier Delattre,et al. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas , 1994, Nature Genetics.
[28] D. Louis,et al. A rapid and non‐radioactive PCR based assay for the detection of allelic loss in human gliomas , 1993, Neuropathology and applied neurobiology.
[29] D. Louis,et al. Subsets of Glioblastoma Multiforme Defined by Molecular Genetic Analysis , 1993, Brain pathology.
[30] D. Pinkel,et al. Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 2022 .
[31] D. Louis,et al. A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens. , 1992, The American journal of pathology.
[32] I. Petersen,et al. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas. , 1992, Cancer research.
[33] I. Petersen,et al. Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. , 1992, Journal of neurosurgery.
[34] I. Petersen,et al. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. , 1992, Cancer research.
[35] C. James,et al. Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[36] P. Kleihues,et al. p53 mutations in nonastrocytic human brain tumors. , 1991, Cancer research.
[37] V. P. Collins,et al. Molecular genetic analysis of chromosome 22 in 81 cases of meningioma. , 1990, Cancer research.
[38] Y. Nakamura,et al. Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma. , 1989, Cancer research.
[39] Y. Nakamura,et al. Allelotype of colorectal carcinomas. , 1989, Science.
[40] C. James,et al. Mitotic recombination of chromosome 17 in astrocytomas. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[41] C. James,et al. Clonal genomic alterations in glioma malignancy stages. , 1988, Cancer research.
[42] V. P. Collins,et al. Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[43] R. Martuza,et al. Molecular genetic approach to human meningioma: loss of genes on chromosome 22. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[44] Hermona Soreq,et al. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin , 1985, Nature.
[45] O. G. Dodge,et al. Histological Typing of tumours of the Central Nervous System , 1981, British Journal of Cancer.
[46] E. B. Jackson,et al. Effects of Colchicine and Radiation on Growth of Normal Tissues and Tumors , 1940 .
[47] J. Cairncross,et al. Gliomas in families: chromosomal analysis by comparative genomic hybridization. , 1998, Cancer genetics and cytogenetics.
[48] D. Lenartz,et al. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. , 1995, The American journal of pathology.
[49] B. Scheithauer,et al. Histological Typing of Tumours of the Central Nervous System , 1993, World Health Organization.